PRODUCT CLASSES
WIDE RANGE OF BIOPHARMACEUTICALS
The product types manufactured with microbial expression systems at Richter BioLogics include proteins and peptides, antibodies (VHH/Nanobodies, Fab-fragments), plasmid DNA, and bacterial vaccines.
Recombinant proteins account for the largest share. But Richter BioLogics has also accumulated extensive experience with many other proteins such as antibodies (e.g. VHH/Nanobodies, Fab-fragments), cytokines, and hormones.
Encouraging therapeutic successes have recently been reported for various gene therapies. Plasmid DNA (pDNA) is an important molecule not only in this field. Plasmids are produced as critical raw materials and serve as starting material for e.g. mRNA and RNAi and provide the DNA template for virus production (e.g. AAV and Lentivirus) and cell-free expression systems. Our scalable, high-performance, proprietary pDNA process RB-pART offers high purification success with high ratio of supercoiled pDNA (≥95 %).
Richter BioLogics has been producing and analytically testing plasmid DNA for nearly 25 years.
OUTSTANDING FLEXIBILITY
The bacterial vaccines produced at Richter BioLogics include living, attenuated, and inactivated whole-cell vaccines, cell fragments, and surface polymers.
Richter BioLogics also leverages considerable experience with and flexibility for complex biopharmaceuticals.
All kinds of microbial-derived biopharmaceuticals can be produced at Richter BioLogics. Protein projects account for the bulk of the manufacturing services we provide, including the cell-free protein synthesis, which is established at all our sites.
This might interest you
35 years of experience with pDNA projects. Audited by major authorities including but not limited to FDA, EMA, PMDA.
More than 35-years track record in gmp production of proteins. From gene of interest to product, we flexibly manufacture your target molecule.
